Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Lieberman

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Mbio|October 21, 2020
Inhibition of Coronavirus Entry <i>In Vitro</i> and <i>Ex Vivo</i> by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC DomainVictor K Outlaw, Francesca T Bovier, Megan C Mears, et al.
Mbio|June 1, 2021
Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the BrainCyrille Mathieu, Francesca T Bovier, Marion Ferren, et al.
Vaccine|June 26, 2025
Immunization with full-length TprC variants induces a broad response to surface-exposed epitopes of the Treponema pallidum repeat protein family and is partially protective in the rabbit model of syphilisLorenzo Giacani, Emily Romeis, Austin Haynes, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
<i>Treponema pallidum</i> periplasmic and membrane proteins are recognized by circulating and skin CD4+ T cellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
The Journal of Infectious Diseases|June 27, 2024
Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T CellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
Communications Biology|January 15, 2025
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunitySaid Mougari, Valérie Favède, Camilla Predella, et al.
Neuro-Oncology|November 1, 2020
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma modelsNicholas A Vitanza, Matt C Biery, Carrie Myers, et al.
The Lancet. Infectious Diseases|January 11, 2024
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trialMaria Ubals, Patricia Nadal-Baron, Maider Arando, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Lineage-specific <i>tprK</i> diversification and <i>Treponema pallidum</i> transmission dynamics in Buenos Aires, ArgentinaNicole A P Lieberman, Luciana N Garcia, Shah A K Mohamed Bakhash, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responsesKatherine J Brempelis, Courtney M Cowan, Shannon A Kreuser, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Mbio|October 21, 2020
Inhibition of Coronavirus Entry <i>In Vitro</i> and <i>Ex Vivo</i> by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC DomainVictor K Outlaw, Francesca T Bovier, Megan C Mears, et al.
Mbio|June 1, 2021
Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the BrainCyrille Mathieu, Francesca T Bovier, Marion Ferren, et al.
Vaccine|June 26, 2025
Immunization with full-length TprC variants induces a broad response to surface-exposed epitopes of the Treponema pallidum repeat protein family and is partially protective in the rabbit model of syphilisLorenzo Giacani, Emily Romeis, Austin Haynes, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
<i>Treponema pallidum</i> periplasmic and membrane proteins are recognized by circulating and skin CD4+ T cellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
The Journal of Infectious Diseases|June 27, 2024
Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T CellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
Communications Biology|January 15, 2025
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunitySaid Mougari, Valérie Favède, Camilla Predella, et al.
Neuro-Oncology|November 1, 2020
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma modelsNicholas A Vitanza, Matt C Biery, Carrie Myers, et al.
The Lancet. Infectious Diseases|January 11, 2024
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trialMaria Ubals, Patricia Nadal-Baron, Maider Arando, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Lineage-specific <i>tprK</i> diversification and <i>Treponema pallidum</i> transmission dynamics in Buenos Aires, ArgentinaNicole A P Lieberman, Luciana N Garcia, Shah A K Mohamed Bakhash, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responsesKatherine J Brempelis, Courtney M Cowan, Shannon A Kreuser, et al.
Pageof 7